03:05 PM EDT, 08/06/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target price by CAD14 to CAD96 supported by a forward P/E of 36.6x compared to BAM's three-year historical average in the low 30.0x range. The premium is supported by the company executing across all business segments in the ALT industry. Given our previous outlook was too optimistic, we reduce our distributed earnings estimates in 2025 by $0.12 to $1.60 and 2026's by $0.10 to $1.90 per share. Our premium valuation for BAM compared to ALT peers that trade in the 20x range is justified by the company's scale and diversified investments and performance track record.